On Behalf of the SFGM-TC: Retrospective Comparison of Reduced and Higher Intensity Conditioning for High-Risk Myelodysplastic Syndrome Treated With Allogeneic Stem-Cell Transplantation.

Date publication

juillet 2021

Journal

Clinical lymphoma, myeloma & leukemia

Auteurs

Membres identifiés du Cancéropôle Est :
Pr RUBIO Marie Thérèse , Dr DAGUINDAU Etienne , Dr D'AVENI-PINEY Maud

Tous les auteurs :
Campidelli A, Robin M, Remen T, Luc A, Labussière-Wallet H, Dulery R, Srour M, Ceballos P, Forcade E, Nguyen-Quoc S, Furst S, Turlure P, Bay JO, Simand C, Marçais A, Daguindau E, Rubio MT, D'Aveni M

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/34456160

Résumé

Allogeneic hematopoietic stem-cell transplantation (allo-HSCT) remains the best curative option for high-risk myelodysplastic syndrome . We retrospectively compared patient outcomes after allo-HSCT according to the intensity of the conditioning regimen.

Mots clés

Allogeneic stem cell transplantation, Conditioning regimen, Covariate adjustment using the propensity, Myelodysplastic syndrome, Overall survival

Référence

Clin Lymphoma Myeloma Leuk. 2021 Jul 31;: